These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 22210681)
1. Combination biologic treatment of refractory psoriasis and psoriatic arthritis. Cuchacovich R; Garcia-Valladares I; Espinoza LR J Rheumatol; 2012 Jan; 39(1):187-93. PubMed ID: 22210681 [No Abstract] [Full Text] [Related]
2. TNFalpha therapy in psoriatic arthritis and psoriasis. Mease P Ann Rheum Dis; 2004 Jul; 63(7):755-8. PubMed ID: 15194567 [No Abstract] [Full Text] [Related]
3. Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial. Prinz JC; Fitzgerald O; Boggs RI; Foehl J; Robertson D; Pedersen R; Molta CT; Freundlich B J Eur Acad Dermatol Venereol; 2011 May; 25(5):559-64. PubMed ID: 20840349 [TBL] [Abstract][Full Text] [Related]
4. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. Gottlieb A; Korman NJ; Gordon KB; Feldman SR; Lebwohl M; Koo JY; Van Voorhees AS; Elmets CA; Leonardi CL; Beutner KR; Bhushan R; Menter A J Am Acad Dermatol; 2008 May; 58(5):851-64. PubMed ID: 18423261 [TBL] [Abstract][Full Text] [Related]
5. Sustained response to long-term biologics and switching in psoriatic arthritis: results from real life experience. Coates LC; Cawkwell LS; Ng NW; Bennett AN; Bryer DJ; Fraser AD; Emery P; Marzo-Ortega H Ann Rheum Dis; 2008 May; 67(5):717-9. PubMed ID: 18055476 [TBL] [Abstract][Full Text] [Related]
6. Superimposed linear psoriasis: low effectiveness of biologic therapy. Colombo L; Marconi M; Mapelli ET; Crespi E; Gualandri L; Menni S; Cerri A G Ital Dermatol Venereol; 2011 Aug; 146(4):311-3. PubMed ID: 21785401 [No Abstract] [Full Text] [Related]
7. Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus. Mikhail M; Weinberg JM; Smith BL Arch Dermatol; 2008 Apr; 144(4):453-6. PubMed ID: 18427038 [No Abstract] [Full Text] [Related]
8. Etanercept: an evolving role in psoriasis and psoriatic arthritis. Prodanovich S; Ricotti C; Glick BP; Inverardi L; Leonardi CL; Kerdel F Am J Clin Dermatol; 2010; 11 Suppl 1():3-9. PubMed ID: 20586498 [TBL] [Abstract][Full Text] [Related]
9. Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review. Brezinski EA; Follansbee MR; Armstrong EJ; Armstrong AW Curr Pharm Des; 2014; 20(4):513-28. PubMed ID: 23565632 [TBL] [Abstract][Full Text] [Related]
10. Anti-tumor necrosis factor alpha therapy in psoriatic arthritis and psoriasis. Girolomoni G; Abeni D Arch Dermatol; 2001 Jun; 137(6):784-5. PubMed ID: 11405771 [No Abstract] [Full Text] [Related]
11. Psoriatic arthritis patients doing better on infliximab than etanercept. Smith N; Gadsby K; Deighton C Rheumatology (Oxford); 2007 Apr; 46(4):721-2. PubMed ID: 17314216 [No Abstract] [Full Text] [Related]
12. [Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society]. Salvarani C; Olivieri I; Cantini F; Marchesoni A; Punzi L; Scarpa R; Matucci-Cerinic M Reumatismo; 2004; 56(3):133-4, 136-8. PubMed ID: 15470517 [No Abstract] [Full Text] [Related]
13. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept]. Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851 [No Abstract] [Full Text] [Related]
14. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics. Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299 [TBL] [Abstract][Full Text] [Related]
15. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions]. Paul C; Solignac M Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165 [No Abstract] [Full Text] [Related]
16. Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis. Capo A; Di Nicola M; Auriemma M; Piaserico S; Cuccurullo C; Santilli F; Davi G; Amerio P Eur J Dermatol; 2014; 24(1):133-5. PubMed ID: 24589526 [No Abstract] [Full Text] [Related]
17. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study. Mazzotta A; Esposito M; Costanzo A; Chimenti S Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444 [TBL] [Abstract][Full Text] [Related]